World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> South African Volunteers Join Oxford COVID-19 Vaccine Trial 23/06/2020 Kerry Cullinan 24 June 2020 (Cape Town, South Africa) – From today, South Africans volunteers will join thousands of people in the UK, US and Brazil in testing a COVID-19 candidate vaccine developed by the Oxford Jenner Institute. The South African Ox1Cov-19 Vaccine VIDA-Trial will involve 2,000 people, including 50 people living with HIV, in a collaboration […] Continue reading -> MMV Releases “COVID Box” Of Compounds Showing Activity Against SARS-CoV-2 Virus To Accelerate Drug Research 19/06/2020 Grace Ren A standardized set of more than 80 compounds with known or predicted activity against SARS-CoV-2, the virus that causes COVID-19, has been compiled by the Medicines for Malaria Venture in an effort to catalyze the discovery of drugs for the disease. The announcement comes amidst rapid shifts in the research around potential COVID-19 treatments. Just […] Continue reading -> World Health Organization To Include Dexamethasone In Updated COVID-19 Care Guidelines; Drops Hydroxychloroquine From Massive Solidarity Trial 17/06/2020 Grace Ren A rising star in the COVID-19 treatment arena, dexamethasone – a powerful corticosteroid – has stirred excitement among World Health Organization experts and researchers around the world, following the publication of promising early results from the United Kingdom’s Recovery trial. In COVID-19 patients only receiving supplemental oxygen, the trial found that dexamethasone reduced mortality by […] Continue reading -> United Kingdom Pauses Massive Hydroxychloroquine Trial After Finding “No Benefit” For COVID-19 Patients; The Lancet Retracts Hydroxychloroquine Paper 04/06/2020 Grace Ren In a series of flip-flops on Friday, the United Kingdom suspended the enrollment of new patients into the hydroxychloroquine arm of its massive RECOVERY trial, one of the largest randomised COVID-19 clinical trials in the world, after preliminary data showed “no benefit” for COVID-19 patients receiving the drug. The suspension of the trial came just […] Continue reading -> Gavi, The Vaccine Alliance Receives Big Private Industry Funding Commitments – Ahead Of Pledging Summit 03/06/2020 Elaine Ruth Fletcher & Grace Ren A day ahead of a major pledging event, Gavi-the Vaccine Alliance has received some US $70 million in pledges from a broad range of corporations, foundations, initiatives and individual philanthropists to modernise, streamline and strengthen its delivery of vaccines to children in the world’s poorest countries over the next 15 years. Meanwhile, Médecins sans Frontières […] Continue reading -> COVID-19 Is Exacerbating Antibiotic Use – And Antimicrobial Resistance Is Rising Fast, WHO Warns 02/06/2020 Svĕt Lustig Vijay As the COVID-19 pandemic spawns increased antibiotic use all over the world, more drug-resistant microbes are bound to bite us back , said Dr. Tedros at a WHO press conference on Monday. The repercussions on disease treatment and deaths will be severe, given that the world is running out of effective ways to treat antimicrobial […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
South African Volunteers Join Oxford COVID-19 Vaccine Trial 23/06/2020 Kerry Cullinan 24 June 2020 (Cape Town, South Africa) – From today, South Africans volunteers will join thousands of people in the UK, US and Brazil in testing a COVID-19 candidate vaccine developed by the Oxford Jenner Institute. The South African Ox1Cov-19 Vaccine VIDA-Trial will involve 2,000 people, including 50 people living with HIV, in a collaboration […] Continue reading -> MMV Releases “COVID Box” Of Compounds Showing Activity Against SARS-CoV-2 Virus To Accelerate Drug Research 19/06/2020 Grace Ren A standardized set of more than 80 compounds with known or predicted activity against SARS-CoV-2, the virus that causes COVID-19, has been compiled by the Medicines for Malaria Venture in an effort to catalyze the discovery of drugs for the disease. The announcement comes amidst rapid shifts in the research around potential COVID-19 treatments. Just […] Continue reading -> World Health Organization To Include Dexamethasone In Updated COVID-19 Care Guidelines; Drops Hydroxychloroquine From Massive Solidarity Trial 17/06/2020 Grace Ren A rising star in the COVID-19 treatment arena, dexamethasone – a powerful corticosteroid – has stirred excitement among World Health Organization experts and researchers around the world, following the publication of promising early results from the United Kingdom’s Recovery trial. In COVID-19 patients only receiving supplemental oxygen, the trial found that dexamethasone reduced mortality by […] Continue reading -> United Kingdom Pauses Massive Hydroxychloroquine Trial After Finding “No Benefit” For COVID-19 Patients; The Lancet Retracts Hydroxychloroquine Paper 04/06/2020 Grace Ren In a series of flip-flops on Friday, the United Kingdom suspended the enrollment of new patients into the hydroxychloroquine arm of its massive RECOVERY trial, one of the largest randomised COVID-19 clinical trials in the world, after preliminary data showed “no benefit” for COVID-19 patients receiving the drug. The suspension of the trial came just […] Continue reading -> Gavi, The Vaccine Alliance Receives Big Private Industry Funding Commitments – Ahead Of Pledging Summit 03/06/2020 Elaine Ruth Fletcher & Grace Ren A day ahead of a major pledging event, Gavi-the Vaccine Alliance has received some US $70 million in pledges from a broad range of corporations, foundations, initiatives and individual philanthropists to modernise, streamline and strengthen its delivery of vaccines to children in the world’s poorest countries over the next 15 years. Meanwhile, Médecins sans Frontières […] Continue reading -> COVID-19 Is Exacerbating Antibiotic Use – And Antimicrobial Resistance Is Rising Fast, WHO Warns 02/06/2020 Svĕt Lustig Vijay As the COVID-19 pandemic spawns increased antibiotic use all over the world, more drug-resistant microbes are bound to bite us back , said Dr. Tedros at a WHO press conference on Monday. The repercussions on disease treatment and deaths will be severe, given that the world is running out of effective ways to treat antimicrobial […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
MMV Releases “COVID Box” Of Compounds Showing Activity Against SARS-CoV-2 Virus To Accelerate Drug Research 19/06/2020 Grace Ren A standardized set of more than 80 compounds with known or predicted activity against SARS-CoV-2, the virus that causes COVID-19, has been compiled by the Medicines for Malaria Venture in an effort to catalyze the discovery of drugs for the disease. The announcement comes amidst rapid shifts in the research around potential COVID-19 treatments. Just […] Continue reading -> World Health Organization To Include Dexamethasone In Updated COVID-19 Care Guidelines; Drops Hydroxychloroquine From Massive Solidarity Trial 17/06/2020 Grace Ren A rising star in the COVID-19 treatment arena, dexamethasone – a powerful corticosteroid – has stirred excitement among World Health Organization experts and researchers around the world, following the publication of promising early results from the United Kingdom’s Recovery trial. In COVID-19 patients only receiving supplemental oxygen, the trial found that dexamethasone reduced mortality by […] Continue reading -> United Kingdom Pauses Massive Hydroxychloroquine Trial After Finding “No Benefit” For COVID-19 Patients; The Lancet Retracts Hydroxychloroquine Paper 04/06/2020 Grace Ren In a series of flip-flops on Friday, the United Kingdom suspended the enrollment of new patients into the hydroxychloroquine arm of its massive RECOVERY trial, one of the largest randomised COVID-19 clinical trials in the world, after preliminary data showed “no benefit” for COVID-19 patients receiving the drug. The suspension of the trial came just […] Continue reading -> Gavi, The Vaccine Alliance Receives Big Private Industry Funding Commitments – Ahead Of Pledging Summit 03/06/2020 Elaine Ruth Fletcher & Grace Ren A day ahead of a major pledging event, Gavi-the Vaccine Alliance has received some US $70 million in pledges from a broad range of corporations, foundations, initiatives and individual philanthropists to modernise, streamline and strengthen its delivery of vaccines to children in the world’s poorest countries over the next 15 years. Meanwhile, Médecins sans Frontières […] Continue reading -> COVID-19 Is Exacerbating Antibiotic Use – And Antimicrobial Resistance Is Rising Fast, WHO Warns 02/06/2020 Svĕt Lustig Vijay As the COVID-19 pandemic spawns increased antibiotic use all over the world, more drug-resistant microbes are bound to bite us back , said Dr. Tedros at a WHO press conference on Monday. The repercussions on disease treatment and deaths will be severe, given that the world is running out of effective ways to treat antimicrobial […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Health Organization To Include Dexamethasone In Updated COVID-19 Care Guidelines; Drops Hydroxychloroquine From Massive Solidarity Trial 17/06/2020 Grace Ren A rising star in the COVID-19 treatment arena, dexamethasone – a powerful corticosteroid – has stirred excitement among World Health Organization experts and researchers around the world, following the publication of promising early results from the United Kingdom’s Recovery trial. In COVID-19 patients only receiving supplemental oxygen, the trial found that dexamethasone reduced mortality by […] Continue reading -> United Kingdom Pauses Massive Hydroxychloroquine Trial After Finding “No Benefit” For COVID-19 Patients; The Lancet Retracts Hydroxychloroquine Paper 04/06/2020 Grace Ren In a series of flip-flops on Friday, the United Kingdom suspended the enrollment of new patients into the hydroxychloroquine arm of its massive RECOVERY trial, one of the largest randomised COVID-19 clinical trials in the world, after preliminary data showed “no benefit” for COVID-19 patients receiving the drug. The suspension of the trial came just […] Continue reading -> Gavi, The Vaccine Alliance Receives Big Private Industry Funding Commitments – Ahead Of Pledging Summit 03/06/2020 Elaine Ruth Fletcher & Grace Ren A day ahead of a major pledging event, Gavi-the Vaccine Alliance has received some US $70 million in pledges from a broad range of corporations, foundations, initiatives and individual philanthropists to modernise, streamline and strengthen its delivery of vaccines to children in the world’s poorest countries over the next 15 years. Meanwhile, Médecins sans Frontières […] Continue reading -> COVID-19 Is Exacerbating Antibiotic Use – And Antimicrobial Resistance Is Rising Fast, WHO Warns 02/06/2020 Svĕt Lustig Vijay As the COVID-19 pandemic spawns increased antibiotic use all over the world, more drug-resistant microbes are bound to bite us back , said Dr. Tedros at a WHO press conference on Monday. The repercussions on disease treatment and deaths will be severe, given that the world is running out of effective ways to treat antimicrobial […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
United Kingdom Pauses Massive Hydroxychloroquine Trial After Finding “No Benefit” For COVID-19 Patients; The Lancet Retracts Hydroxychloroquine Paper 04/06/2020 Grace Ren In a series of flip-flops on Friday, the United Kingdom suspended the enrollment of new patients into the hydroxychloroquine arm of its massive RECOVERY trial, one of the largest randomised COVID-19 clinical trials in the world, after preliminary data showed “no benefit” for COVID-19 patients receiving the drug. The suspension of the trial came just […] Continue reading -> Gavi, The Vaccine Alliance Receives Big Private Industry Funding Commitments – Ahead Of Pledging Summit 03/06/2020 Elaine Ruth Fletcher & Grace Ren A day ahead of a major pledging event, Gavi-the Vaccine Alliance has received some US $70 million in pledges from a broad range of corporations, foundations, initiatives and individual philanthropists to modernise, streamline and strengthen its delivery of vaccines to children in the world’s poorest countries over the next 15 years. Meanwhile, Médecins sans Frontières […] Continue reading -> COVID-19 Is Exacerbating Antibiotic Use – And Antimicrobial Resistance Is Rising Fast, WHO Warns 02/06/2020 Svĕt Lustig Vijay As the COVID-19 pandemic spawns increased antibiotic use all over the world, more drug-resistant microbes are bound to bite us back , said Dr. Tedros at a WHO press conference on Monday. The repercussions on disease treatment and deaths will be severe, given that the world is running out of effective ways to treat antimicrobial […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gavi, The Vaccine Alliance Receives Big Private Industry Funding Commitments – Ahead Of Pledging Summit 03/06/2020 Elaine Ruth Fletcher & Grace Ren A day ahead of a major pledging event, Gavi-the Vaccine Alliance has received some US $70 million in pledges from a broad range of corporations, foundations, initiatives and individual philanthropists to modernise, streamline and strengthen its delivery of vaccines to children in the world’s poorest countries over the next 15 years. Meanwhile, Médecins sans Frontières […] Continue reading -> COVID-19 Is Exacerbating Antibiotic Use – And Antimicrobial Resistance Is Rising Fast, WHO Warns 02/06/2020 Svĕt Lustig Vijay As the COVID-19 pandemic spawns increased antibiotic use all over the world, more drug-resistant microbes are bound to bite us back , said Dr. Tedros at a WHO press conference on Monday. The repercussions on disease treatment and deaths will be severe, given that the world is running out of effective ways to treat antimicrobial […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Is Exacerbating Antibiotic Use – And Antimicrobial Resistance Is Rising Fast, WHO Warns 02/06/2020 Svĕt Lustig Vijay As the COVID-19 pandemic spawns increased antibiotic use all over the world, more drug-resistant microbes are bound to bite us back , said Dr. Tedros at a WHO press conference on Monday. The repercussions on disease treatment and deaths will be severe, given that the world is running out of effective ways to treat antimicrobial […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Posts navigation Older postsNewer posts